Manish Jain decreased his stake in Linde India from 1.97% to 1.96%, selling 6,968 shares.
A leading manufacturer of industrial and medical gases in India, the company produces oxygen, nitrogen, argon, and hydrogen for diverse sectors including steel, chemicals, pharmaceuticals, and healthcare. It also designs and constructs cryogenic and non-cryogenic air separation plants for industrial clients. As a subsidiary of the BOC Group, the company combines international technical expertise with deep local market knowledge to serve industrial and medical applications across India.
Holds a ~₹1,229 Cr disclosed portfolio across 13 stocks, one of the larger HNI books tracked in India. Positions in Linde India, Hester Biosciences, Career Point, and Gandhi Special Tubes reflect a preference for niche industrial and knowledge-sector businesses with strong competitive moats. High conviction, no momentum chasing.